GSK2636771   Click here for help

GtoPdb Ligand ID: 7967

Synonyms: GSK-2636771
Compound class: Synthetic organic
Comment: GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, with anticancer effects in PTEN null cells [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 67.59
Molecular weight 433.16
XLogP 4.47
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)c1cc(cc2c1nc(n2Cc1cccc(c1C)C(F)(F)F)C)N1CCOCC1
Isomeric SMILES OC(=O)c1cc(cc2c1nc(n2Cc1cccc(c1C)C(F)(F)F)C)N1CCOCC1
InChI InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)
InChI Key XTKLTGBKIDQGQL-UHFFFAOYSA-N
Bioactivity Comments
GSK2636771 significantly decreases cell viability in PI3Kβ-reliant PTEN-deficient PC3 prostate and BT549 and HCC70 breast cancer cell lines [3]. It weakly inhibits proliferation of mouse MLg2908 lung fibroblasts (IC50 >20 μM) [1].
We have been unable to find peer-reviewed publicly available data which confirms the action of this compound at its proposed primary molecular target.